# Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

> **NCT00255190** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 591 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Dexlansoprazole MR
- **DRUG:** Dexlansoprazole MR

## Key facts

- **NCT ID:** NCT00255190
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 591 (ACTUAL)
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255190, "Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00255190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*